Using examples and case studies from industry, academia and research literature, Randomized Clinical Trials provides a detailed overview of the key issues involved in designing, conducting, analysing and reporting randomized clinical trials.? It examines the methodology for conducting Phase III clin
Randomized clinical trials. Design, practice and reporting
β Scribed by Peter M. Fayers; David Machin
- Publisher
- Wiley Blackwell
- Year
- 2021
- Tongue
- English
- Leaves
- 535
- Edition
- 2
- Category
- Library
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Content: <br>Chapter 1 Introduction (pages 1β21): <br>Chapter 2 Design Features (pages 23β39): <br>Chapter 3 The Trial Protocol (pages 41β70): <br>Chapter 4 Measurement and Data Capture (pages 71β93): <br>Chapter 5 Randomization (pages 95β111): <br>Chapter 6 Trial Initiation (pages 113β129): <br>Cha
Using examples and case studies from industry, academia and research literature, <i>Randomized Clinical Trials</i> provides a detailed overview of the key issues involved in designing, conducting, analysing and reporting randomized clinical trials.? It examines the methodology for conducting Phase I
<p><i>Randomised Clinical Trials: Design, Practice and Reporting</i> provides a detailed overview of the methodology for conducting clinical trials, including developing protocols, data capture, randomisation, analysis and reporting. Assuming no prior background, this user-friendly resource describe
Rosenberger (mathematics and statistics, University of Maryland) and Lachin (biostatistics and statistics, George Washington University) combine applied aspects of randomization in clinical trials with a probabilistic treatment of properties of randomization in this text/reference for biostatistics
<p><b>Praise for the <i>First Edition</i></b></p> <p><b>βAll medical statisticians involved in clinical trials should read this bookβ¦β</b></p> <p><b>- <i>Controlled Clinical Trials</i></b></p> <p>Featuring a unique combination of the applied aspects of randomization in clinical trials with a nonpara